CHMP Adopts Positive Opinion for Dapivirine Vaginal Ring
The Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Dapivirine Vaginal Ring (dapivirine) for women […]
The Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Dapivirine Vaginal Ring (dapivirine) for women […]
The European Medicines Agency (EMA) has announced in a July 24, 2020 press release that it has started a review of dexamethasone as a treatment […]
Celltrion Healthcare has announced in a July 27, 2020 press release, that the European Commission (EC) has granted marketing authorization for its subcutaneous (SC) formulation […]
A surge in applications to test and develop new cellular and gene therapies is overwhelming staff at FDA s Center for Biologics Evaluation and Research […]
The European Medicines Agency (EMA) has set up an infrastructure to support real-world monitoring of the efficacy and safety of COVID-19 vaccines and treatments, it […]
As the world waits anxiously for more effective COVID-19 treatments and for a vaccine to halt the pandemic, analysts on all sides are examining appropriate […]
FDA announced in July that it plans to resume inspections of some US-regulated facilities this week, but it s not clear how it will decide […]
Global regulatory authorities have published a report describing the aligned positions on COVID-19 vaccine development, which were agreed upon by meeting participants of the second […]
The Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has issued its final opinion on measures for companies to take that […]
FDA announced on July 10, 2020 that it was planning to restart inspections of domestic facilities the week of July 20, dependent on the trajectory […]
With more than 100 vaccine research programs looking to address the pandemic, FDA officials are moving to clarify standards and requirements for vetting and approving […]
The European Commission has approved Lynparza (olaparib) for use in patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer within the European Union, it was revealed […]
The European Directorate for the Quality of Medicines and Healthcare (EDQM) has announced, in a July 1, 2020 press release, the publication of a new […]
Copyright © 2024 | WordPress Theme by MH Themes